[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634037":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":22,"locations":32,"responsibleParty":43,"collaborators":22,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":22,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":22,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":74,"whyStopped":22,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Medipol University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All ECT Patients","EXPERIMENTAL","All enrolled patients will receive both interventions simultaneously. An arterial tourniquet will be applied to one limb (control), and a venous tourniquet followed by regional sugammadex will be applied to the contralateral limb (experimental) during the same ECT session.",[13,14,15],"Device: Device: Arterial Tourniquet","Device: Device: Venous Tourniquet","Drug: Sugammadex",[17,23,27],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DEVICE","Device: Arterial Tourniquet","Within the same patient, the arm without intravenous access is fitted with an arterial tourniquet (\\>250 mmHg or 100 mmHg above systolic BP) before the systemic administration of 0.6 mg\u002Fkg rocuronium.",[9],null,{"type":18,"name":24,"description":25,"armGroupLabels":26,"otherNames":22},"Device: Venous Tourniquet","Within the same patient, the arm with intravenous access receives a venous tourniquet (elastic or 70 mmHg) after systemic rocuronium administration, followed by a regional IV injection of 0.3 mg\u002Fkg sugammadex (diluted in 20 ml saline) into that specific limb.",[9],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":22},"DRUG","Sugammadex","Regional IV injection of 0.3 mg\u002Fkg sugammadex into the experimental limb.",[9],[33],{"facility":34,"status":22,"city":35,"state":22,"zip":22,"country":36,"countryCode":22,"cosmosGeoPoint":37,"geoPoint":42,"contacts":22},"Istanbul Medipol University","Istanbul","Turkey (Türkiye)",{"type":38,"coordinates":39},"Point",[40,41],28.94966,41.01384,{"lat":41,"lon":40},{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"PRINCIPAL_INVESTIGATOR","Burak Omur","Assistant Professor","100634037","venous-tourniquet-vs-arterial-tourniquet-for-seizure-monitoring-in-ect-100634037",false,"NCT07534475","Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT","Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy in Terms of Efficacy and Safety","Inclusion Criteria:\n\n* Patients scheduled for elective Electroconvulsive Therapy (ECT).\n* ASA (American Society of Anesthesiologists) physical status I to III.\n\nExclusion Criteria:\n\n* Known neuromuscular diseases (e.g., Myasthenia Gravis).\n* Known allergy or hypersensitivity to sugammadex, rocuronium, ketamine, dexmedetomidine, or propofol.\n* Presence of venous insufficiency, lymphedema, or active infection in the upper extremities.\n* Severe cardiovascular instability.","ALL","18 Years","65 Years",{"count":58,"type":59},20,"ESTIMATED","INTERVENTIONAL",[62],"NA","This prospective, open-label clinical trial aims to compare a novel \"Venous Tourniquet with Regional Low-Dose Sugammadex\" method against the gold standard \"Arterial Tourniquet\" (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial tourniquet on one arm and a venous tourniquet on the other arm simultaneously. The study will evaluate clinical efficacy in observing motor seizures, comparing the duration and visibility between the two limbs of the same patient, as well as assessing overall patient comfort and hemodynamics.",[65,66,67],"Major Depressive Disorder","Bipolar Disorder","Schizophrenia",[69,70,29,71,72,73],"Electroconvulsive Therapy","Isolated Forearm Technique","Neuromuscular Blockade","Seizure Monitoring","Tourniquet","NOT_YET_RECRUITING","2026-04-16",{"date":77,"type":78},"2026-04-21","ACTUAL",{"date":80,"type":59},"2026-04-20",{"date":82,"type":59},"2026-06-20",{"name":5,"class":6},1]